FA
JAZZ icon

Fiduciary Alliance’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fiduciary Alliance’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$456K Buy
+1,891
New +$414K 0.03% 379
2023
Q1 		– Sell
-33
Closed -$5.26K – 510
2022
Q4 		$5.26K Buy
+33
New +$4.84K ﹤0.01% 523

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Fiduciary Alliance's JAZZ Position: Q2 2026 in Review

Fiduciary Alliance opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 1,891 shares worth $456K. The stake represents 0.03% of the portfolio and ranks #379 among its holdings. This is a return to the name: Fiduciary Alliance previously reported a position in JAZZ as recently as Q4 2022.

Fiduciary Alliance first reported a position in JAZZ in Q4 2022 and has held it in 2 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Fiduciary Alliance held 1,891 shares of Jazz Pharmaceuticals worth $456K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Fiduciary Alliance position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.03% of Fiduciary Alliance's portfolio in Q2 2026, its #379 holding.
  • Fiduciary Alliance first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 2 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.